Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Acta Physiol (Oxf). 2020 Apr 11;229(4):e13471. doi: 10.1111/apha.13471

Table II.

Summary of DHA-GLY effect on cardiovascular parameters in ex-vivo guinea pig hearts.

Parameter Baseline E4031 0.03 μM ΔE4031, compared with baseline DHA-GLY 10 μM ΔDHA-GLY, compared with E4031 ΔDHA-GLY, compared with baseline n
PR interval 58.8 ± 3.6† 61.2 ± 4.2† +2.4 ± 0.9† (P = 0.09) 69.4 ± 4.2† +8.2 ± 2.2† (P ≤ 0.05) +10.6 ± 2.7† (P ≤ 0.05) 6
QRS duration 18.8 ± 0.6† 18.8 ± 0.6† +0.1 ± 0.2† (P = 0.9) 19.1 ± 0.6† + 0.3 ± 0.3† (P = 0.7) + 0.4 ± 0.3† (P = 0.5) 6
Coronary flow 16.2 ± 2.0‡ 14.3 ± 2.0‡ −1.8 ± 0.3‡ (P < 0.01) 12.2 ± 1.8‡ −2.0 ± 2.3‡ (P = 0.7) −3.9 ± 2.2‡ (P = 0.3) 6

Parameters determined during pacing at 250 BPM as described in Methods. Data shown as mean ± sem. Statistics denote repeated measures one-way ANOVA followed by Tukeýs multiple comparison test.

†

denotes ms.

‡

denotes ml/min.